Dare Bioscience, Inc. logo

Dare Bioscience, Inc. (DARE) Q3 2024 Earnings

DARE·Reported November 14, 2024·After market close

Dare Bioscience, Inc. reported Q3 2024 revenue of $41.7K, missed analyst consensus of $1.0M by $958.3K. Diluted EPS came in at $-0.55, beat the $-0.60 consensus by $0.05.

Revenue
$41.7Kmissed by $958.3K
Consensus: $1.0M
Diluted EPS
$-0.55beat by $0.05
Consensus: $-0.60
SEC

SEC Filings

Earnings release8-K not filed yet
Quarterly report10-Q · 0001401914-24-000041

Financial Snapshot

Trailing eight quarters through Q3 2024

View all metrics

Revenue

View metric

Net Income

View metric

Operating Cash Flow

View metric

EPS (Diluted)

View metric

Q3 2024 Earnings FAQ

Common questions about Dare Bioscience, Inc.'s Q3 2024 earnings report.

Dare Bioscience, Inc. (DARE) reported Q3 2024 earnings on November 14, 2024 after market close.

Dare Bioscience, Inc. reported revenue of $41.7K and diluted EPS of $-0.55 for Q3 2024.

Revenue missed the consensus estimate of $1.0M by $958.3K. EPS beat the consensus estimate of $-0.60 by $0.05.

You can read the 10-Q periodic report (0001401914-24-000041) directly on SEC EDGAR. The filing index links above go to sec.gov.